Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists.

Saved in:
Bibliographic Details
Title: Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists.
Authors: Goldenberg RM; LMC Diabetes & Endocrinology, Concord, Ontario, Canada., Gilbert JD; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Manjoo P; Department of Endocrinology, University of British Columbia, and Cardiometabolic Collaborative Clinic, Vancouver Island Health Authority, Vancouver, British Columbia, Canada., Pedersen SD; C-ENDO Diabetes & Endocrinology Clinic Calgary, Calgary, Alberta, Canada., Woo VC; Section of Endocrinology, Health Sciences Centre, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Lovshin JA; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Source: Obesity reviews : an official journal of the International Association for the Study of Obesity [Obes Rev] 2024 Mar; Vol. 25 (3), pp. e13663. Date of Electronic Publication: 2023 Nov 15.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Publishing Country of Publication: England NLM ID: 100897395 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1467-789X (Electronic) Linking ISSN: 14677881 NLM ISO Abbreviation: Obes Rev Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37968541
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Goldenberg+RM%22">Goldenberg RM</searchLink>; LMC Diabetes & Endocrinology, Concord, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Gilbert+JD%22">Gilbert JD</searchLink>; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Manjoo+P%22">Manjoo P</searchLink>; Department of Endocrinology, University of British Columbia, and Cardiometabolic Collaborative Clinic, Vancouver Island Health Authority, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Pedersen+SD%22">Pedersen SD</searchLink>; C-ENDO Diabetes & Endocrinology Clinic Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Woo+VC%22">Woo VC</searchLink>; Section of Endocrinology, Health Sciences Centre, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Lovshin+JA%22">Lovshin JA</searchLink>; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100897395%22">Obesity reviews : an official journal of the International Association for the Study of Obesity</searchLink> [Obes Rev] 2024 Mar; Vol. 25 (3), pp. e13663. <i>Date of Electronic Publication: </i>2023 Nov 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Publishing%22">Blackwell Publishing </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100897395 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1467-789X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214677881%22">14677881 </searchLink><i>NLM ISO Abbreviation: </i>Obes Rev <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37968541
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/obr.13663
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e13663
    Titles:
      – TitleFull: Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Goldenberg RM
      – PersonEntity:
          Name:
            NameFull: Gilbert JD
      – PersonEntity:
          Name:
            NameFull: Manjoo P
      – PersonEntity:
          Name:
            NameFull: Pedersen SD
      – PersonEntity:
          Name:
            NameFull: Woo VC
      – PersonEntity:
          Name:
            NameFull: Lovshin JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2024 Mar
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1467-789X
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Obesity reviews : an official journal of the International Association for the Study of Obesity
              Type: main
ResultId 1